Aurobindo Pharma standalone net profit declines 4.15% in the June 2016 quarter
Sales rise 7.65% to Rs 2328.58 crore
Net profit of Aurobindo Pharma declined 4.15% to Rs 391.03 crore in the quarter ended June 2016 as against Rs 407.95 crore during the previous quarter ended June 2015. Sales rose 7.65% to Rs 2328.58 crore in the quarter ended June 2016 as against Rs 2163.14 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales2328.582163.14 8 OPM %24.3327.80 -PBDT573.42606.19 -5 PBT503.02543.04 -7 NP391.03407.95 -4Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content